Plant lignans and isoflavones that have estrogen-like properties, are classified as phytoestrogens based on their activities and chemical structures.
Because ingested plant lignans undergo metabolic degradation, their transformation and metabolites have been extensively studied. [8] [9] [10] [11] [12] [13] The mammalian lignans, enterolactone (ENL) and enterodiol (END), are of considerable interest since their isolation from the urine of humans and other animals in 1980. 14) Subsequent studies have verified that the origins of mammalian lignans are plant lignans and that intestinal bacteria play a critical role in the formation of ENL and END. [15] [16] [17] [18] Intestinal bacteria metabolize plant lignans by processes such as deglucosylation, demethylenation, ring cleavage, demethylation, dehydroxylation and oxidation. Several human intestinal bacteria that function in these processes have been isolated and characterized. 10, 11, [19] [20] [21] [22] However, ENL and END have two enantiomeric, mirror image forms. The ENL that is transformed via the anaerobic incubation of pinoresinol diglucoside (PDG) from Eucommia ulmoides OLIV. with intestinal bacteria, assumes the (Ϫ)-form. 10) On the other hand, the ENL that is obtained via incubation with secoisolariciresinol diglucoside (SDG) from flaxseed, assumes the (ϩ)-form. 13) We investigated which bacteria are involved in the transformation of the respective enantiomeric forms.
The human intestinal bacteria, Eggerthella (Eg.) sp. SDG-2 and strain ARC-1 enantioselectively dehydroxylate dihydroxyenterolactone (DHENL) and dihydroxyenterodiol (DHEND). 23) Eg. sp. SDG-2 converted (Ϫ)-DHENL and (ϩ)-DHEND to (Ϫ)-ENL and (ϩ)-END, respectively, but not to the respective enantiomers, (ϩ)-DHENL and (Ϫ)-DHEND. Conversely, strain ARC-1 converted (ϩ)-DHENL and (Ϫ)-DHEND to (ϩ)-ENL and (Ϫ)-END, respectively, but not to the enantiomers (Ϫ)-DHENL and (ϩ)-DHEND.
Moreover, the bacterial strains, strain END-2 and Ruminococcus (R.) sp. END-1, which oxidize END to ENL were isolated from human feces. 24) When strain END-2 was incubated with a mixture of (ϩ)-END and (Ϫ)-END, only (ϩ)-END was oxidized to (ϩ)-ENL, and (Ϫ)-END remained unchanged (Fig. 1) . Conversely, R. sp. END-1 converted only (Ϫ)-END to (Ϫ)-ENL.
Here, we further describe the substrate specificity and cooperative behavior of strain END-2 with strain ARC-1 during the metabolism of plant lignans.
MATERIALS AND METHODS
General Fecal suspensions and intestinal bacteria were incubated in an anaerobic model EAN-140 incubator (Tabai Co., Osaka, Japan). Optical rotations were measured in MeOH using a DIP-360 automatic polarimeter (Jasco Co., Tokyo, Japan Chemicals and Media General anaerobic medium (GAM) was purchased from Nissui Co. (Tokyo, Japan). Brain heart infusion broth was purchased from Becton Dick- 27) and we prepared (Ϫ)-2-(3Љ,4Љ-dihydroxybenzyl)-3-(3Ј,4Ј-dimethoxybenzyl)butane-1,4-diol from (Ϫ)-SME as follows: a bacterial suspension (25 ml) of strain END-2 was inoculated into 250 ml of GAM broth containing (Ϫ)-SME (20 mg) and incubated at 37°C in an anaerobic incubator for 108 h. The reaction mixture was then extracted three times with 250 ml of ethyl acetate. The organic layer was evaporated under reduced pressure to yield a residue (81.5 mg) that was eluted through a column of Sephadex LH-20 with H 2 O-MeOH (15 mg) . This compound was identified by comparing the 1 H-and 13 C-NMR, to reported spectra. 28, 29) LC/MS Analysis Samples were analyzed by HPLC/MS using an Agilent 1100 system (Agilent Technologies, Waldbronn, Germany) with a photodiode array detector and an Agilent 1100 series binary pump, together with an Esquire 3000plus mass spectrometer (Bruker Daltonic GmbH, Bremen, Germany) coupled with an electrospray ionization (ESI) interface and an ion trap mass analyzer. The conditions were as follows: column, TSK-gel ODS-80Ts (Tosoh Co., Tokyo, Japan, 4.6ϫ150 mm); mobile phase, 0.1% trifluoroacetic acid (TFA, solvent system A) and CH 3 CN (solvent system B) in gradient modes [(Ϫ)-END, (Ϫ)-ENL and enterolactol analysis, B from 20 to 50% for 30 min; analysis of (Ϫ)-arctigenin and its metabolites, B from 25 to 26.4% in 60 min; analysis of diol-type compounds, B from 20 to 40% in 20 min]; flow rate, 1.0 ml/min; detection, UV at 280 nm; temperature, 30°C. High-purity nitrogen was the dry gas at a flow rate at 10 l/min, at 360°C. Helium was the nebulizer at 50 psi. The ESI interface and mass spectrometric parameters were optimized to obtain maximal sensitivity.
Bacterial Growth and Time Course of Biotransformation A bacterial suspension of strain END-2 (500 ml) was incubated in GAM broth (5 ml) containing (ϩ)-END (final concentration, 0.2 mM) at 37°C under anaerobic conditions and then a portion (100 ml) was extracted with ethyl acetate. The ethyl acetate was evaporated in vacuo, and then the residue was dissolved in 0.3 ml of MeOH and filtered through a 0.45 mm membrane. A portion (10 ml) of the filtrate was separated at room temperature by HPLC using a CCPM-II (Tosoh, Tokyo, Japan) equipped with a Tosoh UV-8020 spectrometer and a Shimadzu C-R8A chromatopac (Shimadzu, Kyoto, Japan) under the following conditions: column, TSK-gel ODS-80Ts (Tosoh Co., Tokyo, Japan, 4.6 mmϫ150 mm); mobile phase, 0.1% TFA (solvent system A) and CH 3 CN (solvent system B) in gradient mode (B from 30 to 50% in 20 min); flow rate, 1.0 ml/min; detection, UV 280 nm. Concentrations of (ϩ)-END and (ϩ)-ENL were calculated from calibration curves generated from the respective authentic samples. Optical density at 540 nm was measured with a UV-2200 UV-VIS recording spectrophotometer (Shimadzu Co., Kyoto, Japan).
Substrate Specificity Each substrate (0.2 mM) was anaerobically incubated with strain END-2 for 120 h, and then a portion (100 ml) was extracted with ethyl acetate. The ethyl acetate was evaporated in vacuo and then the residue was dissolved in MeOH (50 ml) and filtered through a 0.45-mm membrane. A portion (10 ml) of the filtrate was analyzed by LC/MS. Substrate conversion was also confirmed by TLC.
Co-incubation of Strains END-2 and ARC-1 Each substrate (0.1 mM) was anaerobically incubated with R. sp. END-1 and strain ARC-1 for 120 h, and then a portion (100 ml) was extracted with ethyl acetate, which was then evaporated in vacuo. The residue was dissolved in 0.3 ml of MeOH, filtered through a 0.45-mm membrane and a portion (10 ml) was analyzed by LC/MS. Substrate conversion was also confirmed by TLC. Figure 2 shows the kinetics of the transformation of 0.2 mM (ϩ)-END to (ϩ)-ENL by strain END-2 in GAM broth. Strain END-2 reached an optical density of about 0.7 at 540 nm under anaerobic conditions for 2 d and metabolic activity was evident during growth. The amount of (ϩ)-END decreased from 27 h, then the amount of (ϩ)-ENL was appreciably increased. The concentration of (ϩ)-ENL reached the maximum after 75 h. A metabolic intermediate was detected during cultivation, but not quantified because the amount was very small. Analysis by LC/MS (Fig. 3) revealed that the MS spectrum of the intermediate contained a quasi-molecular ion peak of m/z 323 [MϩNa] ϩ , which was 2 mass units higher and lower than those of ENL and END respectively, suggesting that the intermediate was a reduction product (enterolactol) of ENL. A comparison of the retention time and mass fragment pattern with those of synthetic enterolactol confirmed that the intermediate was indeed enterolactol.
RESULTS

Bacterial Growth and Biotransformation of (؉)-END to (؉)-ENL by Strain END-2
Demethylation Activity of Strain END-2 Strain END-2 not only oxidized, but also demethylated compounds during the transformation of mammalian lignan precursors. The strain demethylated (Ϫ)-SECO to (Ϫ)-DHEND (Fig. 4) , but did not convert (Ϫ)-SME to (Ϫ)-DHEND. Only a methoxy group at C-3Ј was eliminated to yield (Ϫ)-2-(3Ј,4Ј-dihydroxybenzyl)-3-(3Љ,4Љ-dimethoxybenzyl)butane-1,4-diol. Strain END-2 also selectively demethylated lactone type lignans. All methoxy groups of (Ϫ)-matairesinol and of (Ϫ)-2-(4Ј-hydroxy-3Ј-methoxybenzyl)-3-(3Љ-hydroxy-4Љ-methoxybenzyl) butyrolactone were eliminated to yield (Ϫ)-DHENL (Fig. 5) . However, (Ϫ)-arctigenin was converted to (Ϫ)-2-(3Ј,4Ј-dihy-droxybenzyl)-3-(3Љ,4Љ-dimethoxybenzyl)butyrolactone.
Transformation of Secoisolariciresinols by Strain END-2 and ARC-1 Co-incubation
We detected END in EtOAc extracts from anaerobically incubated suspensions of (Ϫ)-SECO and strains END-2 and ARC-1 at 37°C. Analytical LC/MS with a chiral column showed that END was the (Ϫ) enantiomer. Strain END-2 demethylated and strain ARC-1 dehydroxylated (Ϫ)-SECO during its bioconversion to (Ϫ)-END (Fig. 6) . In a similar incubation, strain END-2 demethylated and oxidized (ϩ)-SECO, whereas strain ARC-1 dehydroxylated (ϩ)-SECO to yield (ϩ)-ENL.
DISCUSSION
Several plant lignans such as SDG, PDG, arctiin, sesamin, matairesinol, 7Ј-hydroxymatairesinol, isolariciresinol, lariciresinol, syringaresinol and even dietary lignins have been identified as precursors of mammalian lignans.
8,12,30,31) Many grains, seeds, vegetables and fruits contain these precursors. [32] [33] [34] Thus, many investigators have attempted to verify the biological activities of mammalian lignans. Not only estrogenic and antiestrogenic, 35, 36) but also antioxidant 37, 38) and anticancer [39] [40] [41] [42] 
activities of ENL and END have been demonstrated in vitro and in vivo.
Intestinal bacteria are indispensable for precursor lignans to transform and exhibit the biological activities of mammalian lignans. This is supported by the fact that mammalian lignans are undetectable in the urine of germ-free rats, but present in that from rats associated with human-flora. 43) Moreover, oral antimicrobials decrease serum ENL concentrations. 44) Among the metabolic processes performed by intestinal bacteria, the oxidation of dibenzylbutane-1,4-diols to butyrolactones is essential for the formation of ENL from plant lignans such as PDG, SDG and sesamin. Strain END-2 and R. sp. END-1 that can oxidize END to ENL have been isolated from human feces. 24) These two strains enantioselectively converted END to ENL; the former converted (ϩ)-END to (ϩ)-ENL and the latter converted (Ϫ)-END to (Ϫ)-ENL. Moreover, Clavel et al. reported that strain ED-Mt61/PYGs6, which is classified as Lactonifactor (L.) longoviformis (DQ100449), produces ENL from human feces. 20, 22) Incubating L. longoviformis with Clostridium saccharogumia (DQ100445, deglucosylation), Peptostreptococcus (P.) productus SECO-Mt75m3 (AY937379, demethylation), Eg. lenta SECO-Mt75m2 (AY937380, dehydroxylation), converted SDG from flaxseed to ENL. Because the enantiomeric excess of (ϩ)-SECO is about 97% for flaxseed, 45) L. longoviformis might convert (ϩ)-END to (ϩ)-ENL, like strain END-2. The 16S ribosomal RNA gene sequences of L. longoviformis and of strain END-2 are 96% similar. 24) Strain END-2 oxidized (ϩ)-DHEND to (ϩ)-DHENL indicating that the para hydroxyl group in the phenyl rings is not involved in the enantioselective oxidation. The oxidation by R. sp. END-1 also proceeds regardless of the presence or absence of a para hydroxyl group in the phenyl rings. 25) It means that the oxidation by two strains can influence dehydroxylation by Eg. sp. SDG-2 and strain ARC-1.
23)
After incubating (ϩ)-END with strain END-2, a small amount of 3,4-bis(3-hydroxybenzyl)-tetrahydrofuran-2-ol (enterolactol) was detected as an intermediate. However, the amount generated was too small to accurately quantify, which might explain why the production of enterolactol as an intermediate during the biotransformation of precursor lignans has not been described. On the other hand, (Ϫ)-lactol has been detected during the metabolism of plant lignans, since SECO dehydrogenase from Forsythia intermedia converts (Ϫ)-SECO to (Ϫ)-matairesinol via (Ϫ)-lactol.
26) The SECO dehydrogenase also functions during the enantioselective oxidation of SECO.
Strain END-2 showed not only oxidation but also demethylation activity during the biotransformation of mammalian lignan precursors. When the strain was incubated with (Ϫ)-SME, only the 3Ј-methoxy group was degraded to produce 2-(3,4-dihydroxybenzyl)-3-(3,4-dimethoxybenzyl)-butane-1,4-diol. However, (Ϫ)-SECO was converted to (Ϫ)-DHEND through demethylation of all methoxy groups by the strain, showing that a free hydroxyl group adjacent to the methoxy group is necessary for demethylation as in P. sp. strain SDG-1.
11) We also incubated (Ϫ)-arctigenin with strain END-2. Similarly, only the 3Ј-methoxy group was degraded to produce 2-(3,4-dihydroxybenzyl)-3-(3,4-dimethoxybenzyl)butyrolactone, indicating that selective degradation of a methoxy group with a vicinal hydroxyl group is not affected by the g-lactone or butane-1,4-diol moiety in the molecule. However, several plant lignans such as arctiin and styraxlignolide F 46) with two adjacent methoxy groups in its phenyl rings transform to mammalian lignans. Collaborative and/or competitive demethylation with other bacteria such Eubacterium sp. ARC-2 that can demethylate without selectivity might occur in the human gastrointestinal tract. Furthermore, considering that all of the methoxy groups of either (ϩ)-or (Ϫ)-SECO were also degraded, the demethylation activity of strain END-2 is not enantioselective for substrates.
An incubation of (ϩ)-SECO and (Ϫ)-SECO with a mixture of strains END-2 and ARC-1, resulted in the generation of (ϩ)-ENL and (Ϫ)-END, respectively. Because strain ARC-1 can dehydroxylate only the (ϩ)-form of DHENL or the (Ϫ)-form of DHEND, the oxidation activity of strain END-2 influences dehydroxylation by strain ARC-1. Strain ARC-1 can participate in the transformation of (ϩ)-SECO to (ϩ)-ENL, only after lactonization by bacteria such as strain END-2. Moreover, once (Ϫ)-SECO is lactonized by some bacteria such as R. sp. END-1, strain ARC-1 cannot dehydroxylate, indicating that the composition and number of responsible bacteria influence the transformation of precursor, to mammalian lignans.
